BAA-19-00123 - pmwp#125 - efficacy of chronic opioid pain treatments: an RCT RE-analysis

Ended Definitive Contract Awarded Last action

Contract number
75F40120C00175
Awardee
Awarding agency
Obligated
$1,082,140

Award facts

Opportunity
  • BAA1900123PMWP125 Solicitation number
Contract value 100% obligated
$1,082,140.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition · 11 offers Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Philadelphia, PA 19104, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00009 $0
Terminate for Convenience P00008 · EOI::{HHS cost efficiency initiative}:: EOI. Termination for convenience $0
Other Administrative Action P00007 $0
Other Administrative Action P00006 · No cost modification to change the period of performance end date to march 29, 2026 $0
Other Administrative Action P00005 $0
Other Administrative Action P00004 $0
Other Administrative Action P00003 · No cost time extension due to covid delays $0
Other Administrative Action P00002 · IPP clause modification $0
Other Administrative Action P00001 $0
Original award $1,082,140

About this award

This is a $1,082,140.00 firm fixed price definitive contract awarded by the Food and Drug Administration (FDA) to The Trustees of the University of Pennsylvania, operating as the University of Pennsylvania, to conduct a randomized controlled trial re-analysis on the efficacy of chronic opioid pain treatments. The contract was awarded under Broad Agency Announcement BAA-19-00123, with a period of performance through May 1, 2025. This contract does not have a set-aside designation. The University of Pennsylvania has a long history of conducting biomedical research, data analysis, and other scientific activities supporting public health objectives as a prime contractor for federal agencies. The University has also participated as a subcontractor on numerous federal grants and contracts issued to other research institutions.

Quick answers

Who was awarded contract 75F40120C00175?

75F40120C00175 was awarded to The Trustees Of The University Of Pennsylvania by Food and Drug Administration (Department of Health and Human Services) on September 28, 2020.

How much is contract 75F40120C00175 worth?

The government has obligated $1,082,140 on 75F40120C00175.

Was contract 75F40120C00175 competed?

The extent of competition for 75F40120C00175 was full and open competition. The government received 11 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award